第79届世界卫生大会在日内瓦召开，各国通过了20多项决议，涉及中风、肝病、结核病、抗微生物耐药性、诊断成像等多个卫生领域1。大会批准了WHO全球卫生体系改革方案、《WHO全球卫生工作者国际招聘实践守则》修订版、2026-2030年全民卫生经济学战略、首项辐射与卫生综合决议，以及2026-2036年全球抗微生物耐药性行动计划1。
抗微生物耐药性问题成为本届大会重点关注的议题。据统计，2023年全球六分之一的常见细菌感染对抗生素治疗产生耐药性1。研究估计2021年有471万例死亡与细菌抗微生物耐药性相关1。若不采取行动，抗微生物耐药性可能在2050年前导致3900万例死亡1。为此，大会新制定的战略旨在2030年实现联合国大会2024年确定的目标：细菌抗微生物耐药性相关死亡减少10%1。目前，超过170个国家已制定抗微生物耐药性多部门国家行动计划，104个国家在2025年向WHO监测系统报告了相关数据1。
《WHO全球卫生工作者国际招聘实践守则》自2010年通过以来首次更新1。此次修订反映了卫生工作者伦理国际招聘的最新要求1。
The Seventy-ninth World Health Assembly convened in Geneva and adopted more than 20 resolutions addressing critical global health challenges 1. Among the major decisions, member states approved WHO's global health system reform, updates to the international code of practice on ethical recruitment of health workers, the 2026-2030 Universal Health Economics Strategy, the first comprehensive resolution on radiation and health, and the 2026-2036 Global Action Plan on Antimicrobial Resistance 1.
The assembly's focus on antimicrobial resistance reflects growing urgency surrounding the threat. In 2023, one-sixth of common bacterial infections demonstrated resistance to antibiotic treatment globally 1. Research estimates that 4.71 million deaths in 2021 were associated with bacterial antimicrobial resistance, with projections indicating that without intervention, this figure could reach 39 million deaths by 2050 1. The updated 2026-2036 Action Plan aims to reduce deaths related to bacterial antimicrobial resistance by 10 percent by 2030, in line with a target set by the United Nations General Assembly in 2024 1.
Progress on antimicrobial resistance surveillance and policy development has been substantial, with more than 170 countries having established multisectoral national action plans to address the issue 1. Additionally, 104 countries reported antimicrobial resistance data to WHO's monitoring system in 2025 1. The WHO's code of practice on ethical recruitment of health workers underwent its first major revision since its adoption in 2010, representing a 16-year interval 1.
评论
还没有评论，欢迎留下第一条。